Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290401 · ClinicalTrials.gov registry record · Phase 2
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
A Phase 2 study of Anemia, Sickle Cell, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 310
- Enrollment target
- 4
- Study locations
NCT06290401 is a Phase 2 study of Anemia, Sickle Cell that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 310 participants, above the 100-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (210% higher). The trial reports 4 study locations across 4 states.
The verdict
NCT06290401, a Phase 2 study of Anemia, Sickle Cell, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 310 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency room visits in 260 adolescents and young adults with sickle cell disease (SCD) ages 13-21 receiving care at 1 of 4 pediatric SCD clinics. The main question\[s\]it aims to answer are: * Does SCThrive improve patient activation? * Does SCThrive improve self-management behaviors, daily functioning, and decrease emergency room visits? * Are any improvements maintained 3 months after treatment? Participants will complete self-management related surveys before, after, and 3 months following their participation in an 8- week, virtual group intervention with an accompanying mobile app (SCThrive). Researchers will compare outcomes for participants who receive SCThrive and participants who receive uniform standard care (SCHealthED which = standard of care plus SCD educational text messages) to see if there are differences in patient activation, self-management behaviors, daily functioning, and emergency room visits.
Conditions Studied
Interventions
- BEHAVIORAL SCThrive
- OTHER SCHealthED
Study Locations (4)
Delaware
- Nemours Children's Health - Wilmington
Georgia
- Children's Healthcare of Atlanta - Atlanta
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2028-06-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06290401
The ClinicalTrials.gov registry entry for NCT06290401 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 100-participant average among 17 other Anemia, Sickle Cell trials with a reported enrollment target (210% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anemia, Sickle Cell appearing as the primary indexed condition, and to 2 interventions - of which SCThrive is the first listed.
NCT06290401 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Delaware, Georgia, Ohio.
Frequently Asked Questions
What is clinical trial NCT06290401 about?
NCT06290401 is a clinical study titled "A Socio-ecological Approach for Improving Self-management in Adolescents With SCD". The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily functioning, and emergency room visits in 260 adolescents and young adults with sickle cell disease (SCD) ages 13-21 receiving car...
What is the current status of trial NCT06290401?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 310 participants. The study started on 2025-02-03. Estimated completion is 2028-06-30.
What conditions does trial NCT06290401 study?
This clinical trial studies the following conditions: Anemia, Sickle Cell.
What interventions are being tested in trial NCT06290401?
The interventions under investigation include: SCThrive (BEHAVIORAL), SCHealthED (OTHER).
Who is sponsoring clinical trial NCT06290401?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290401 being conducted?
This trial has 4 study locations across Delaware, Georgia, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia, Sickle Cell
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
COMPLETED · Phase 2
-
Nitric Oxide Inhalation to Treat Sickle Cell Pain Crises
COMPLETED · Phase 2
-
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RECRUITING · Phase 1
-
Metabolic and Hemodynamic Reserve in Pediatric SCA
RECRUITING · NA
-
A Blood Stem Cell Transplant for Sickle Cell Disease
ACTIVE NOT RECRUITING · Phase 1
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.